Back to search
FDAFDA · Food and drugs·Recall number D-0638-2022

RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.

Published February 23, 2022 · Recall initiated: February 8, 2022

Summary

FDA records drug Class I recall D-0638-2022, published February 23, 2022 and initiated February 8, 2022. Recalling firm: Celebrate Today; Status: Terminated; Reported quantity: 500 cartons; Lot: Lot # DK1027, Exp. 08/01/2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Celebrate Today
Distributor
Product was distributed nationwide in the USA via Amazon Marketplace
Lot
Lot # DK1027, Exp. 08/01/2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5. recalled?

Yes. FDA published recall D-0638-2022 on February 23, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release